INOVOTION PUBLICATION

We are thrilled to share with you our latest peer-reviewed publication in 

"Frontiers in Immunology" on the chicken embryo’s relevance for immune-based studies.

In this review, we compare the human and chicken embryo immune systems, and explain how the latter can be used as a model for immuno-oncology drug development. 

INOVOTION METASTATIC ASSAY

Since 2018, the FDA recommends metastasis-free survival (MFS) as an endpoint in drug trials for some prostate cancers.

At INOVOTION, we have developed a unique, highly sensitive in vivo metastatic assay to easily determine the efficiency of your oncology drug candidates for over 50 in vivo cancer models.

Discover our metastasis webinar: Preclinical evaluation of antimetastatic drug candidates using a next-generation chicken embryo model

INOVOTION NUMBERS

Here at INOVOTION, we are proud of what we have achieved with our customers in the last 6 years.

With over 100 clients worldwide, we are now a reference in the preclinical testing landscape.

Find out why our customers rely on us and our cutting-edge technology! 

CLIENT POSTER

CPD Weill Cornell Medicine-Qatar leverages on INOVOTION’s cutting-edge

technology, and presented the results at Metabolomics 2021.

Try the Next-Generation solution that more and more clients are relying on, and

optimize your preclinical drug discovery with our fast and unique in vivo platform !

CLIENT TESTIMONIAL

Affilogic is biotech company specialized in discovery and development of Nanofitins(R) as innovative biotherapeutics with worldwide industry leaders.

At INOVOTION, we like to work with very innovative client research projects for fighting cancer.

We enjoy helping our customers get access to in vivo immuno-oncology data.

Interested in optimising your preclinical drug discovery?

Contact us for an open discussion or to come and visit our labs !

CLIENT PUBLICATION

Allowing our customers to get their first proof-of-concept for in vivo activities of their innovative treatments is always a very exciting moment, which opens new perspectives for their drug discovery projects.

If you too are interested in optimizing your preclinical drug discovery with our powerful in vivo technology platform, please contact us for a free quote! 

UPCOMING EVENTS WHERE YOU CAN MEET US:

- PREDiCT: 6th Annual Tumor Models IO 

25-27 January

- 3rd Annual Advances in Immuno-Oncology USA Congress

7-8 Febuary

- NLSDays 2022

20-21 April

ABOUT US 

Optimizing your preclinical and Drug Discovery studies is of prime importance, and INOVOTION has developed a solution based on its unique and cutting-edge in vivo technology.

As a Contract Research Organization (CRO) dedicated to in vivo evaluation for Drug Discovery mainly in oncology and immuno-oncology, INOVOTION is a sought-after partner for Pharma and Biotech companies as well as academic labs all over the world.

Our main missions are to:

• Help you find the best candidate anti-cancer treatment
• Detect the first in vivo toxicity effects of your candidate compounds
• Improve productivity and Return-On-Investment of your preclinical and Drug Discovery process by maximizing your lead optimization phase 
• Accelerate the overall Drug Discovery process to answer unmet medical needs in oncology.

Any questions about Inovotion's technology? 

Contact us at : contact@inovotion.com

INOVOTION SAS
HQ & Lab Facilities

+33 475 549 512

5 ave du Grand Sablon
38700 La Tronche
France

INOVOTION Inc

185 Alewife Brook Parkway, Suite 210
Cambridge, MA 02138

USA

This email was sent to [[EMAIL_TO]] for marketing purposes. If it is not of interest to you, please disregard and we apologize for any inconvenience this may have caused. To prevent further emails, click here: Manage your preferences